Human Ochratoxicosis

References

• Austwick P. K.C. Balkan nephropathy. The Practitioner 1981; 225: 1031–1038
   PubMedGoogle Scholar
• Bacha H., Maaroufi K., Achour A., Hammami M., Ellouz F., Creppy E. E. Ochratoxines et ochratoxicoses humaines en Tunisie. Human Ochratoxicosis and its Pathologies, EE Creppy, M. Castegnaro, G. Dirheimer. Colloque INSERM/John Libbey, Eurotext Ltd, LondonUnited Kingdom 1993; 231: 111–121
   Google Scholar
• Baudnmont I., Ahouandjivo R., Creppy E. E. Prevention of lipid peroxidation induced by ochratoxin A in Vero cells in culture by several agents. Chem. Biol. Int. 1997; 104: 29
   PubMedGoogle Scholar
• Bauer J., Gareis M. Ochratoxin A in der Nahrungsmittelkette. Z. Veterinmed 1987; 34: 613–627
   PubMedGoogle Scholar
• Bemdt W. O., Hayes A. W. In vivo and in vitro changes in renal functions caused by ochratoxin A in the rat. Toxicology 1979; 12: 5–17
   PubMedGoogle Scholar
• Boussarie M. A partir dune etude cas-temoins Etude du role de ltochratoxine A chez lthomme dans la survenue de niphropathies interstitielles d'ktiologie indeterminée. Memoire DEA Methodes d'Analyse des Systemes de Santé. Universite de Rennes. 1997; 1
   Google Scholar
• Breitholtz A., Olsen M., Dahlback A., Hult K. Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit. Contam. 1991; 8: 1983–92
   Google Scholar
• Bunge I., Heller K., Roschenthaler R. Isolation and purlfication of ochratoxin A. Z. Lebensm. Unters. Forsch. 1979; 168: 457–458
   Google Scholar
• Castegnaro M., Bartsch H., Bereziat J. C., Arvela P., Michelon J., Broussole L. Polymorphic ochratoxin A hydroxylation in rats strains phenotyped as poor and extensive metabolizers of debrisoquine. Xenobiotica 1989; 19: 225–230
   PubMed Web of Science ®Google Scholar
• Castegnaro M., Maru V., Petkova-Bocharova T., Nicolov I. G., Bartsch H. Concentration of ochratoxin A in the urine of endemic nephropathy patients and controls in Bulgaria: lack of detection of 4-hydroxyochratoxin A. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, M. Castegnaro, R. Plestina, G. Dirheimer, I. N. Chernozemski, H. Bartsch. IARC Scientific Publication. 1991; 115: 165–169
   Google Scholar
• Ceovic S., Hrabar A., Saric M. Epidemiology of Balkan Endemic Nephropathy. Fd. Chem. Toxic 1992; 3: 188, 1983
   Google Scholar
• Creppy E. E., Schlegel M., Roschenthaler R., Dirheimer G. Combined action of citrinin and ochratoxin A on hepatoma tissue culture cells. Toxicol. Letters 1980; 5: 375–380
   PubMed Web of Science ®Google Scholar
• Creppy E. E., Stormer F. C., Roschenthaler R., Dirheimer G. Effects of two metabolites of ochratoxin A, (4R)-4-hydroxyochratoxin A and ochratoxin alpha, on immune response in mice. Infection and Immunity 1983; 39(3)1015–1018
   PubMedGoogle Scholar
• Creppy E. E., Roschenthaler R., Dirheimer G. Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine. Food Chem. Toxicol. 1984; 22(11)883–886
   PubMed Web of Science ®Google Scholar
• Creppy E. E., Kane A., Dirheimer G., Lafarge-Frayssinet C., Mousset S., Frayssinet C. Genotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen liver and kidney. Toxicol. Lett. 1985; 28: 29–35
   PubMed Web of Science ®Google Scholar
• Creppy E. E., Betbeder A. M., Sanchez D., Gharbi Khalef A., Gauret Counord J., Dirheimer G., Bacha H., Hadidane R., Hammami M., El May M., Achour A., Zidane C. Human ochratoxicosis in Northen Africa, correlation with cases of nephropathy. Justus Liebig Universitat Giessen. Mykotoxin-Workshop 1992; 14: 67–68
   Google Scholar
• Creppy E. E., Betbeder A. M., Gharbi A., Counord J., Castegnaro M., Bartsch H., Moncharmont P., Fouillet B., Chambon P., Duheimer G. Human ochratoxicosis in France. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, M. Castegnaro, R. Plestina, G. Dirheimer, LN. Chernozemsky, H. Bartsch. IARC Scientific Publications, Lyon 1991; 145–151, No. 115
   Google Scholar
• Creppy E. E., Castegnaro M., Grosse Y., Meriaux J., Manier C., Moncharmont P., Waller C. Etude de l'ochratoxicose humaine dans trots regions de France: Alsace, Aquitaine et region Rhone-Alpes. Human Ochratoxicosis and its Pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. Colloque INSERM/John Libbey, Eurotext Ltd, LondonUnited Kingdom 1993; vol 231: 147–158
   Google Scholar
• Creppy E. E., Betbeder A. M., Godin M., Fillastre J. P., Amg K. S., Simon P., Lasseur C., Combe C., Aparicio M. Ochratoxin A in human blood and chronic interstitial nephropathy: cases report in France. Proceedings 17. Mykotoxin-Workshop in der Bundesforschungsanstalt fur Landwirtschaft Braunschweig-Volkenrode. FAL, 15–17 May, 1995-1995
   Google Scholar
• Creppy E. E., Baudrimont I., Betbeder A. M. Prevention of nephrotoxicity of ochratoxin A, a food contaminant. Toxicol. Lett. 1995; 82/83: 869–877
   Web of Science ®Google Scholar
• Creppy E. E., Baudrimont I., Belmadani A., Betbeder A. M. Aspartame as a preventive agent of chronic toxic effects of ochratoxin A in experimental animals. 3. Toxicol. Toxin Rev. 1996; 15(3)207–221
   Web of Science ®Google Scholar
• De Groene E. M., Hassing G. I.A., Blom M. J., Seinen W., Fink-Gremmels J., Horbach G. J. Development of human cytochrome P450 expressing cell lines; application in mutagenicity testing of ochratoxin A. Cancer Res. 1996a; 56: 299–304
   PubMed Web of Science ®Google Scholar
• De Groene E. M., Jahn A., Horbach G. J., Fink-Gremmels J. Mutagenicity and genotoxicity of the mycotoxin ochratoxin A. Environ. Toxicol. Parmacol. 1996b; 1: 21–26
   PubMed Web of Science ®Google Scholar
• Dirheimer G. Mechanistic approaches to ochratoxin A toxicity. Food Addit. Contam. 1996; 13: 45–48
   PubMedGoogle Scholar
• Fukui Y., Hayasaka I., Itoh M., Takouchi Y. Development of neurons and synapses in ochratoxin A - induced microcephalic mice: a quantitative assessment of somatosensory cortex. Neurotoxicology and Teratology 1992; 14: 191–196
   PubMedGoogle Scholar
• Galtier P., Alvinerie M., Charpenteau J. L. The pharmacokinetic profiles of ochratoxin A in pigs, rabbits and chickens. Food Cosmet. Toxicol. 1981; 19: 735–738
   PubMedGoogle Scholar
• Godin M., Francois A., Le Roy F., Monn J. P., Creppy E. E., Hemet J., Fillastre J. P. Karyomegalic interstitial nephritis. Am. J. Kidney Diseases 1996; 27(1)166
   PubMedGoogle Scholar
• Hadidane R., Bacha H., Creppy E. E., Hammami M., Ellouz F., Dirheimer G. Isolation and structure determination of natural analogues of the mycotoxin ochratoxin A produced by Aspergillus ochraceus. Toxicology 1992; 76: 233–243
   PubMed Web of Science ®Google Scholar
• Hult K., Plestina R., Ceovic S., Habazin-Novak V., Radic B. Ochratoxin A in human blood: Analytical results and confirmational tests from a study in connection with Balkan Endemic Nephropathy. Proceedings, V International IUPAC Symposium on Mycotoxins and Phycotoxins. Austrian Chem. Soc, Vienna, Austria 1982a; 338–341, Sept. 1–3, 1982
   Google Scholar
• Hult K., Plestina R., Habazin-Novak V., Radic B., Ceovic S. Ochratoxin A in human blood and Balkan endemic nephropathy. Arch. Toxicol. 1982; 51: 313–321
   Web of Science ®Google Scholar
• IARC (International Agency for Research on Cancer)Some naturally occuring substances: Some food items and constituents, spices, pyrolysis products and mycotoxins. IARC monographs on the evaluation of carcinogenic risks to humans, Lyon 1993; volume 56
   Google Scholar
• Kane A., Creppy E. E., Roschenthaler R., Dirheimer G. Changes in urinary and renal tubular enzymes caused by subchronic adrmnistration of ochratoxin A in rats. Toxicology 1986; 42: 233–243
   PubMedGoogle Scholar
• Kanisawa M., Suzuki S. Induction of renal and hepatic tumours in mice by ochratoxin A, a mycotoxin. Gann. 1978; 69: 599–600
   PubMedGoogle Scholar
• Kanisawa M. Synergistic effects of citrinin on hepatorenal carcinogenesis of OTA in mice. Toxigenic Fungi - Their Toxins and Health, H. Hazard Kurata, Y. Ueno, Kodansha, Tokyo/Elsevier, Amsterdam 1984; 245–254
   Google Scholar
• Kawamura O., Malu S., Sato S., Ueno Y. Ochratoxin A in livestock and human sera in Japan quantified by a sensitive ELISA. Human Ochratoxicosis and its Pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. Colloque INSERM/John Libbey, Eurotext Ltd, LondonUK 1993; 231: 159–165
   Google Scholar
• Khalef A., Zidane C., Charef A., Gharbi IA., Tadjerouna M., Betbeder A. M., Creppy E. E. Ochratoxicose humaine en Algerie. Human Ochratoxicosis and its Pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. Colloque INSERM/John Libbey, Eurotex, LondonUK 1993; 231: T123–127
   Google Scholar
• Krogh P., Hald B., Pedersen E. J. Occurrence of ochratoxin A and citrinin in cereals associated with porcine nephropathy. Acta Pathol. Microbiol. Scand. (B) 1973; 81: 689–695
   Google Scholar
• Krogh P., Axelsen N. H., Wiling F., Gyrd-Hansen N., Hald B., Hylgaard-Jensen J., Hen A. E., Madsen A., Mortensen H. P., Moller T., Petersen O. K., Ravnskov U., Rostgaard M., Aalund O. Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin Asontamin ated feed. Acta Pathol. Microbiol. Scand. (A) 1974; 246: 1–21
   Google Scholar
• Krogh P. Ochratoxins. Mycotoxins in Human and Animal health, J. V. Rodricks, C. W. Esseltine, M. A. Mehlmann. Pathotox Pub, Illinois 1977; 489–498
   Google Scholar
• Krogh P. Ochratoxins in food. Mycotoxin in Food, P. Krogh. Academic Pres, New York 1987; S97–121
   Google Scholar
• Kuiper-Goodman T., Scott P. M. Risk Assessment of the mycotoxin ochratoxin A. BiornedicaLand Environmental Sciences 1989; 2: 179–248
   Google Scholar
• Kuiper-Goodman T., Ominski K., Marquardt R. R., Malcolm S., Mc Mullen E., Lombaert G. A., Morton T. Estimating human exposure to ochratoxin A in Canada. Human Ochratoxicosis and its Pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. Colloque INSERM/John Libbey, Eurotext Ltd, LondonUK 1993; 231: 167–174
   Google Scholar
• Maaroufi K., Achour A., Hammami M., El May M., Betbeder A. M., Ellouz F., Creppy E. E., Bacha H. Ochratoxin A in human blood in relation to nephropathy in Tunisia. Hum.& Exper. Toxicology 1995a; 14: 609–615
   Google Scholar
• Maaroufi K., Achour A., Betbeder A. M., Hammami M., Ellouz F., Creppy E. E., Bacha H. Foodstufs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia. Arch. Toxicol. 1995b; 69: 552–558
   PubMed Web of Science ®Google Scholar
• Maaroufi K., Achour A., Zakhama A., Ellouz F., El-May M., Creppy E. E., Bacha H. Human nephropathy related to Ochratoxin A in Tunisia. J. ToxicoL-Toxin Review 1996; 15(3)223–237
   Google Scholar
• Manolova Y., Manolov G., Parvanova L., Petkova-Bocharova T., Castegnaro M., Chernozemsky I. N. Induction of characteistic chromosomal aberrations, particularly X-trisomy, in cultured human Iymphocytes treated by ochratoxin A, a mycotoxin implicated in Balkan endemic nephropathy. Mutat. Res. 1990; 292: 143–149
   Google Scholar
• Mantle P. G., McHugh K. M., Adatia R., Heaton J. M., Gray T., Turner D. R. Penicillium aurantiognseum-induced, persistent renal hispathological changes in rats, an experimental model for Balkan endemic nephropathy competitive with ochratoxin A. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, M. Castegnaro, R. Plestina, G. Dirheimer, H. N. Chernozemsky, H. Bartsch. International Agency for Research on Cancer, LyonFrance 1991; 119–27
   Google Scholar
• Mantle P. G., McHugh K. M. Nephrotoxic fungi in foods from nephropathy households in Bulgaria. Mycol. Res. 1993; 97: 205–212
   Web of Science ®Google Scholar
• Mayura K., Parker R., Berndt W. O., Phillips T. D. Ochratoxin A - induced teratogenesis in rats: partial protection by phenylalanine. Appl. Environ. Microbiol. 1984; 48: 11861188
   Google Scholar
• Meisner H., Meisner P. Ochratoxin A, in vivo inhibitor of renal phosphoenolpyruvate carboxykinase. Arch. Biochem. Biophys. 1981; 208: 146–153
   PubMed Web of Science ®Google Scholar
• NTP (National Toxicology Program)NTP Technical Report on the Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303–47–9) in F3441N Rats (Gavage studies), G. Boorman. US Department of Health and Human Services, National Institutes of Health. Research Trianglc Park, NC 1989, NIH Publication No. 89–2813
   Google Scholar
• Olsen J. H., Hald B., Thorup I. Carstensen Distribution in Denmark of porcine nephropathy and chronic disorders of the urinary tract in humans. Human Ochratoxicosis and its Pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. Colloque INSERM/John Libbey, Eurotext Ltd, LondonUK 1993; 231: 209–216
   Google Scholar
• Petkova-Bocharova T., Chemorernski I. N., Castegnaro M. Ochratoxin A in human blood in relation to Balkan Endemic Nephropathy and unnaq system tumours in Bulgaria. Food Addit. Contam 1988; 5(3)199–301
   Google Scholar
• Petkova-Bocharova T., Castegnaro M. Ochratoxin A in human blood in relation to Balkan endemic nephropathy and unnary tract tumours in Bulgana. Mycotoxins. Endemic Nephropathy and Urinary Tract Tumours, M. Castegnaro, R. Plestina, G. Dirheimer, I. N. Chemozemsky, H. Bailsch. IARC Scientific Publications, Lyon 1991; 115: 135–137
   Google Scholar
• Rahimtula A. D., Bereziat J. C., Bussachini-Griot V., Bartsch H. Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem. Parmacol. 1988; 37: 4469–4477
   PubMed Web of Science ®Google Scholar
• Speijers G. J.A., van Egmond H. P. Worldwide ochratoxin A levels in food and feeds. Human ochratoxicosis and its Pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. Colloque INSERM/John Libbey Eurotext Ltd. 1993; 231: 85–100
   Google Scholar
• Steyn P. S., Holzapfel C. W., Ferreira N. P. Biosynthesis of the ochratoxins, metabolites of Aspergillus ochraceus. Phytochem. 1970; 9: 1977–1983
   Web of Science ®Google Scholar
• Steyn P. S., Holzapfel C. W. The isolation of the methyl and ethyl esters of ochratoxins A and B, metabolites of Aspergillus ochruccus. Wilh. J. S. Afr. Chem. Inst. 1967a; 20: 186189
   Google Scholar
• Steyn P. S., Holzapfel C. W. The synthesis of ochratoxins A and B, metabolites of Aspergillus ochraceus. With. Tetrahedron 1967b; 23: 4449–4461
   PubMed Web of Science ®Google Scholar
• Suzuki S., Moroi K., Kanisawa M., Satoh T. Effects of drug metabolizing enzyme inducers on carcinogenesis and toxicity of ochratoxin A in mice. (Abstract). Toxicol. Letters 1986; 31: 206, Suppl
   Google Scholar
• Thuvander A., Breitholtz-Emanuelson A., Brabencova D., Gadhasson I. Influence of perinatal ochratoxin A exposure on the immune system in mice. Food Chem. Toxicol. 1996; 34(6)547–554
   PubMedGoogle Scholar
• Thuvander A., Dahl P., Breitholtz-Emanuelson A. Prenatal exposure of Balb/c mice to ochratoxin A: effects on the immune system in the offsprings. Nat. Toxins 1997; 4(4)174–180
   Google Scholar
• van der Menve K. J., Steyn P. S., Foune L. Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus With. Nature 1965a; 205(4976)112–1113
   Google Scholar
• van der Merwe K. J., Steyn P. S., Foune L. Mycotoxins Part II. The constitution of ochratoxins A, B and C, metabolites of Aspergillus ochraceus With. J. Chem. Soc 1965b; 7083–7088
   Google Scholar
• van Egmond H. P., Speijers G. J.A. Survey of data on the incidence and levels of ochratoxin A in food and animal feed world-wide. J. Nat. Tox. 1994; 3(2)125–144
   Google Scholar
• Wafa E. W., Yahya R. S., Sobh M. A., Eraky I., El-Baz M., El-Gayar H. A.M., Betbeder A. M., Creppy E. E. Human & Experimental. Toxicology 1998; 17: 124–129
   Google Scholar